Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-065926

Options or other derivatives

  • EVP, COO, Head of Commercial acquired 79,302 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Teehan Brendan EVP, COO, Head of Commercial 2021-11-17 Grant or award · Restricted Stock Units +39,651 39,651 D
Teehan Brendan EVP, COO, Head of Commercial 2021-11-17 Grant or award · Restricted Stock Units +39,651 39,651 D
Loading xslF345X03/doc4.xml…